In a periodontitis model, the SP-MT hydrogel group showed higher bone mineral density (BMD), increased bone volume fraction (BV/TV), reduced CEJ-ABC distance, and significantly lower inflammatory cytokine levels (TNF-α, IL-6), providing an innovative platform for precise treatment of chronic infectious bone defects [157]. The gene discussed is TNF; the disease is periodontitis.